BioCentury
ARTICLE | Clinical News

Cethrin regulatory update

September 22, 2008 7:00 AM UTC

The EC granted Orphan Drug designation for Cethrin to treat traumatic spinal cord injury (SCI). The recombinant C3 exoenzyme protein, a Rho GTPase antagonist, mixed with a fibrin sealant also has Orp...